SC 13D

Company

Stoke Therapeutics, Inc.

Filed

July 1, 2019

Accession Number

0001193125-19-186323

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →